-
cfRRBS on cfDNA from pediatric cancer
Study
EGAS00001004194
-
RNA Editing in breast cancer
Study
EGAS00001000495
-
Latency and interval therapy affect the evolution in metastatic colorectal cancer
Study
EGAS00001003646
-
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
Study
EGAS00001004405
-
The landscape of chromothripsis across adult cancer types
Study
EGAS00001004250
-
Pediatric Patient-Derived-Xenograft development in MAPPYACTS – international pediatric cancer precision medicine trial in relapsed and refractory tumors
Study
EGAS00001007327
-
Targeted_sequencing_of_genes_recurrently_mutated_in_AML
Study
EGAS00001000408
-
RNA sequencing of Non-Small Cell Lung Cancer and adjacent normal tissue
Study
EGAS50000000246
-
Identification of the genes associated with EGFR-mutant lung cancer
Study
JGAS000129
-
Myeloma_Targeted_Follow_up_Study
Study
EGAS00001000880
-
Sequencing_of_patient_samples_who_received_immune_checkpoint_inhibition___WES___NKI
Study
EGAS00001003154
-
Targeted_NanoSeq_Sperm
Study
EGAS00001005920
-
Role_of_HPV_and_Interferon_in_APOBEC_mutational_signature
Study
EGAS00001002988
-
Single cell RNA sequencing of colorectal cancer patients (CRC-SG1)
Study
EGAS00001006013
-
Bulk RNA-seq of stromal cells from multiple cancer types
Study
EGAS00001006497
-
Detection of rare mutations, copy number variation, and DNA methylation in the same template DNA molecules
Study
EGAS00001006839
-
Genetic Determinants of Viral Clearance in HCV-Infected Populations
Study
phs000248
-
Genomics of Hepatocellular Carcinoma
Study
phs001106
-
Finnish_population_cohort_genotyping_B
Study
EGAS00001001047
-
Mutational signatures of aflatoxin
Study
EGAS00001002490
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
5- FU treated organoids
Study
EGAS00001003592
-
cfDNA dataset from extracelular vesicles and paired non-fractionated samples
Study
EGAS00001006848
-
Multisite_Breast_Cancer_Whole_Genome
Study
EGAS00001000890
-
Whole genome bisulfite sequencing of prostate cancer samples upon oral pimonidazole administration
Study
EGAS50000000069
-
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML
Study
EGAS50000000347
-
SCANDARE HNSCC
Study
EGAS50000001158
-
ICGC PanCancer Analysis of Whole Genomes
Study
EGAS00001001692
-
Mesothelioma_Whole_Genomes
Study
EGAS00001000830
-
GENOMIC INSTABILITY IN MISMATCH REPAIR DEFICIENT COLORECTAL CANCER
Study
EGAS00001002477
-
Chondromyxoid_fibroma
Study
EGAS00001000533
-
Targeted_NanoSeq_Buccal
Study
EGAS00001005925
-
Poikiloderma_syndrome_RNAseq
Study
EGAS00001000250
-
Effect_of_FAM50_knockout_on_the_transcriptome
Study
EGAS00001004836
-
HTAN MCL Pre-Cancer Atlas Pilot Project - Targeted Sequencing Development Study
Study
phs002225
-
Genomics from LCCC1525: A Priming Dose of Cyclophosphamide Prior to Pembrolizumab to Treat mTNBC
Study
phs002659
-
Targeted Long-Read Sequencing of the Ewing Sarcoma 6p25.1 Susceptibility Locus
Study
phs003159
-
Merkel Cell Carcinoma Tissue and Data Repository
Study
phs002189
-
FinaleMe: Predicting DNA Methylation by the Fragmentation Patterns of Plasma Cell-Free DNA
Study
phs003287
-
Divergent WNT Signaling and Drug Sensitivity Profiles within Hepatoblastoma Tumors and Organoids
Study
EGAS50000000561
-
A non-canonical lymphoblast in refractory childhood T-cell leukaemia
Study
EGAS50000000767
-
Whole exome sequencing of uterine adenomyosis
Study
JGAS000169
-
Linking genes, genomic instability and molecular subgroups in medulloblastoma
Study
EGAS00001000085
-
HCA_Female_Reproductive_Adult_WSSS_RNA
Study
EGAS00001004727
-
Whole exome sequencing on Pediatric MDS patients
Study
EGAS00001005432
-
The aim of this study was to identify underlying hub genes and dysregulated pathways associated with the development of HCC using bioinformatics analysis.
Study
EGAS00001002526
-
Single cell exome sequencing of lung adenocarcinoma
Study
EGAS00001002972
-
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Study
EGAS00001004888
-
Personalized Onco-Genomic Project for pediatric and adolescent patients in British Columbia
Study
EGAS00001006967
-
Genetic landscape of pediatric Infant Acute Lymphoblastic leukemia
Study
EGAS00001000246